Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,945,134
-$15,076,158 QoQ
Shares Held
57,906
-76.9% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Empowered Funds, LLC holds $226,794,169 across 58 Biotechnology names. PTCT ranks #14 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
353,386 | $33,260,686 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
384,538 | $24,852,688 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,737 | $18,637,235 | |
| 4 | EXEL |
Exelixis, Inc.
|
335,606 | $14,394,138 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,618 | $12,067,088 | |
| 6 | ASND |
Ascendis Pharma A/S
|
51,135 | $11,696,107 | |
| 7 | RPRX |
Royalty Pharma plc
|
228,996 | $10,984,937 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
137,220 | $8,603,693 |
All Filings in PTCT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,945,134 | 57,906 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $19,021,292 | 250,412 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,682,175 | 43,705 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $2,076,041 | 42,507 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $1,999,058 | 39,228 | Shares | Other | 2025-05-16 | |
| 2024-03-31 | $1,210,085 | 41,598 | Shares | Other | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||